FACTOR VIII DEFICIENCY
Clinical trials for FACTOR VIII DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new FACTOR VIII DEFICIENCY trials appear
Sign up with your email to follow new studies for FACTOR VIII DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New treatment aims to protect hemophilia Patients' joints from damage
Disease control Recruiting nowThis study is testing whether a weekly medication called efanesoctocog alfa can reduce joint swelling (synovial hypertrophy) in people with hemophilia A. About 35 participants aged 12 and older with existing joint swelling will receive the treatment for 12 months. Researchers wil…
Matched conditions: FACTOR VIII DEFICIENCY
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
Massive study tracks 4,000 kids with rare bleeding disorder
Knowledge-focused Recruiting nowThis study is creating a large European registry to collect information about children with haemophilia A or B. Researchers will follow 4,000 children born between 2000 and 2040 to better understand why some develop antibodies against their treatment (inhibitors) and how the dise…
Matched conditions: FACTOR VIII DEFICIENCY
Sponsor: PedNet Haemophilia Research Foundation • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Massive 15-Year study launches to track safety of new blood disorder drugs
Knowledge-focused Recruiting nowThis study aims to collect long-term safety and effectiveness data on treatments for various non-cancerous blood disorders, including hemophilia, von Willebrand disease, and platelet disorders. It will follow up to 3,000 participants for at least 15 years to see how newer, FDA-ap…
Matched conditions: FACTOR VIII DEFICIENCY
Sponsor: American Thrombosis and Hemostasis Network • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC